Palantir's stock was surging 6.3% in recent trading, enough to lead the S&P 500's winners, after the AI-play said it plans to change its listing exchange to the Nasdaq from the N ...

Currently, only 21% of Wall Street analysts have Palantir ranked a "buy". This makes Palantir the lowest recommended, best ...

Prof. Schoppmann, AKH Vienna, on 40 ineffective esophageal motility (IEM) patients treated with RefluxStop™ published in Scientific Reports, a Nature journal Dr. med. Zehetner (Prof. USC) on first 40 ...

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that nine of its facilities earned an "A" Hospital Safety Grade from ...